Joel Greenblatt's ROIV Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 1.35 M shares of Roivant Sciences Ltd. (ROIV) worth $47.76 M, representing 0.11% of the portfolio. First purchased in 2024-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in ROIV, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 594,718 shares. Largest reduction occurred in Q2 2026, reducing 66,626 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Roivant Sciences (ROIV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Roivant Sciences (ROIV) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -66,626 | Reduce 4.70% | 1.35 M | $35.39 |
| Q1 2026 | +490,898 | Add 53.06% | 1.42 M | $27.70 |
| Q4 2025 | +594,718 | Add 179.96% | 925,193 | $21.70 |
| Q3 2025 | +291,326 | Add 744.15% | 330,475 | $15.13 |
| Q2 2025 | +122 | Add 0.31% | 39,149 | $11.27 |
| Q3 2024 | -510 | Reduce 1.29% | 39,027 | $11.54 |
| Q2 2024 | +39,537 | New Buy | 39,537 | $10.57 |
Joel Greenblatt's Roivant Sciences Investment FAQs
Joel Greenblatt first purchased Roivant Sciences Ltd. (ROIV) in Q2 2024, acquiring 39,537 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Roivant Sciences Ltd. (ROIV) for 9 quarters since Q2 2024.
Joel Greenblatt's largest addition to Roivant Sciences Ltd. (ROIV) was in Q4 2025, adding 925,193 shares worth $20.08 M.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 1,349,465 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $47.76 M.
As of the Q2 2026 filing, Roivant Sciences Ltd. (ROIV) represents approximately 0.11% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Roivant Sciences Ltd. (ROIV) was 1,416,091 shares, as reported at the end of Q1 2026.